First-line treatment selection with organoids of an <i>EGFR</i>m + <i>TP53</i>m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up.

Jia, Ziqi; Wang, Yanyu; Cao, Lei; Wang, Yadong; Song, Yang; Yang, Xiaoying; Bing, Zhongxing; Cao, Zhili; Liu, Peng; Zhang, Shuyang; Chen, Zexin; Huang, Min; Yu, Yan; Han-Zhang, Han; Song, Jinlei; Christoph, Daniel C; Passaro, Antonio; Gridelli, Cesare; Hishida, Tomoyuki; Liang, Naixin; Li, Shanqing

First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up.

Jia, Ziqi; Wang, Yanyu; Cao, Lei; Wang, Yadong; Song, Yang; Yang, Xiaoying; Bing, Zhongxing; Cao, Zhili; Liu, Peng; Zhang, Shuyang; Chen, Zexin; Huang, Min; Yu, Yan; Han-Zhang, Han; Song, Jinlei; Christoph, Daniel C; Passaro, Antonio; Gridelli, Cesare; Hishida, Tomoyuki; Liang, Naixin; Li, Shanqing.

Afiliación

Jia Z; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Wang Y; Eight-Year MD Program, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Cao L; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Wang Y; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Song Y; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Yang X; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Bing Z; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Cao Z; Eight-Year MD Program, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Liu P; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Zhang S; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Chen Z; Medical Research Center, Central Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Huang M; Medical Research Center, Central Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Yu Y; Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Han-Zhang H; Accurate International Biotechnology Co. Ltd., Guangzhou, China.
Song J; Accurate International Biotechnology Co. Ltd., Guangzhou, China.
Christoph DC; Accurate International Biotechnology Co. Ltd., Guangzhou, China.
Passaro A; Burning Rock Biotechnology Co. Ltd., Guangzhou, China.
Gridelli C; Burning Rock Biotechnology Co. Ltd., Guangzhou, China.
Hishida T; Department of Medical Oncology/Haematology, Evang. Kliniken Essen-Mitte, Essen, Germany.
Liang N; Division of Thoracic Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Li S; Division of Medical Oncology, "S.G. Moscati" Hospital, Contrada Amoretta, 83100, Avellino, Italy.

J Thorac Dis ; 12(7): 3764-3773, 2020 Jul.

Article en En | MEDLINE | ID: mdl-32802455

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Thorac Dis Año: 2020 Tipo del documento: Article País de afiliación: China